ArticleBMC chemistry2026
A novel pyridine-functionalized naphthoxazine: thermal stability, proton and metal ion-responsive optical sensing, and biological activity with DFT validation.
Article in BMC chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Designing multifunctional polymers that combine thermal stability, selective optical response, and biological activity remains a key challenge in smart materials development. Herein, we report a novel pyridine-functionalized naphthoxazine monomer (Py-NZ) synthesized via a one-pot Mannich condensation and fully characterized by 1D/2D NMR, FTIR, and HRMS. DFT calculations confirmed the optimized geometry, showing excellent agreement with experimental data (RMSD = 0.018 Å; mean IR error = 0.43%), validating its extended π-conjugated structure. Thermogravimetric analysis of the cured Poly(Py-NZ) revealed outstanding thermal stability, with a char yield of 69% at 800 °C and a limiting oxygen index (LOI) of 45.1, indicating strong flame-retardant potential. UV-Vis and fluorescence spectroscopy demonstrated that metal coordination significantly modifies the optical behavior. Among the tested metal ions, Zn²⁺ induced a marked fluorescence enhancement due to its d¹⁰ configuration, which suppresses nonradiative decay and favors radiative emission. Py-NZ also exhibited strong acid-responsive fluorescence: high HCl concentrations quenched emission via protonation-induced nonradiative pathways, while lower acidity restored intensity, confirming its dual-responsive chemosensing capability for both metal ions and protons. Biological evaluation showed moderate antibacterial activity against Staphylococcus aureus and Escherichia coli, with the protonated form exhibiting enhanced activity against Gram-positive bacteria (MIC = 15.6 µg/mL). In DPPH antioxidant assays, all compounds displayed dose-dependent reductive activity comparable to ascorbic acid, with the Zn²⁺-coordinated complex showing the highest potency of nanomolarity radical scavenging affinities (IC₅₀ = 0.15 ± 0.01 vs. 0.041 ± 0.0062 for ascorbic acid). Overall, this work establishes a versatile platform for naphthoxazine-based multifunctional materials with potential applications in flame-retardant coatings, optical sensing, and biomedical fields.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.